MYC is of particular interest as a target in glioblastoma, given that it regulates about 15% of the entire genome, modulating cell proliferation, differentiation, survival, and apoptosis [42], and dysregulation in MYC signaling contributes to tumorigenesis [43]. The gene discussed is MYC; the disease is glioblastoma.